Biotechnology

The global biotechnology industry is one of the most agile and fastest-growing sectors in modern science and medicine, fueled by advancements in genetic engineering, personalized medicine, and novel therapeutics. India's biotech industry, as reported by Invest India, is fast emerging as one of the prime drivers of economic and technological progress, and it contributes approximately 4% to the world's biotech market, with exemplary capabilities in agricultural biotechnology, biopharmaceuticals, and vaccines.

This broad market covers key subcategories such as biopharmaceuticals, bioservices, and biotechnology R&D, each covering necessary segments of scientific innovation, therapeutic development, and commercial biotechnology applications in various industries like healthcare, agriculture, and industrial biotechnology. The biopharmaceutical segment shows outstanding growth prospects with the total biopharmaceutical market worldwide pegged at USD 422.5 billion in 2024, growing from USD 453.7 billion in 2025 to USD 921.5 billion in 2034 at a CAGR of 8.2%, fueled by rising demands for targeted therapies and biologics.

Support for biotechnology R&D infrastructure shows remarkable momentum. The bioreactors market was valued at USD 10.4 billion in 2023 and will grow at 11.8% CAGR from 2024 to 2032, while the contract research organization (CRO) market will reach USD 59.8 billion in 2023 and expand at 8.1% CAGR from 2024 to 2032, supported by increasing public and private R&D spending worldwide. Each of these niches illustrates the commitment of this sector to improved scientific discovery and therapeutic development.

Growth drivers include aging populations worldwide, the rising prevalence of chronic disease, government incentives for new therapies, and significant venture capital funding into biotechnology. The industry enjoys the benefits of cutting-edge manufacturing tools, trends toward personalized medicine, and pro forma collaborations between biotech firms and large pharmaceutical companies. Gene editing, cell therapies, artificial intelligence integration, and precision medicine advances continue to transform therapeutic research and commercial biotechnology products in all biotechnology submarkets.